Role of NSC319726 in ovarian cancer based on the bioinformatics analyses

References

• PerrenTJSwartAMPfistererJICON7 InvestigatorsA phase 3 trial of bevacizumab in ovarian cancerN Engl J Med20113652484249622204725
   PubMed Web of Science ®Google Scholar
• ShinerABurbosNOvarian cysts and ovarian cancerInnovAiT20125547557
   Google Scholar
• Cancer Genome Atlas Research NetworkIntegrated genomic analyses of ovarian carcinomaNature201147460961521720365
   PubMed Web of Science ®Google Scholar
• Fung-Kee-FungMOliverTElitLOzaAHirteHBrysonPOptimal chemotherapy treatment for women with recurrent ovarian cancerCurr Oncol20071419517938703
   PubMedGoogle Scholar
• Pujade-LauraineEWagnerUAavall-LundqvistEPegylated liposomal doxorubicin and carboplatin compared with paclitaxel and carboplatin for patients with platinum-sensitive ovarian cancer in late relapseJ Clin Oncol2010283323332920498395
   PubMed Web of Science ®Google Scholar
• YuXVazquezALevineAJCarpizoDRAllele-specific p53 mutant reactivationCancer Cell20122161462522624712
   PubMed Web of Science ®Google Scholar
• PetitjeanAMatheEKatoSImpact of mutant p53 functional properties on tp53 mutation patterns and tumor phenotype: lessons from recent developments in the iarc tp53 databaseHum Mutat20072862262917311302
   PubMed Web of Science ®Google Scholar
• AhmedAAEtemadmoghadamDTempleJDriver mutations in tp53 are ubiquitous in high grade serous carcinoma of the ovaryJ Pathol2010221495620229506
   PubMed Web of Science ®Google Scholar
• BykovVJIssaevaNZacheNReactivation of mutant p53 and induction of apoptosis in human tumor cells by maleimide analogsJ Biol Chem2005280303843039115998635
   PubMed Web of Science ®Google Scholar
• FosterBACoffeyHAMorinMJRastinejadFPharmacological rescue of mutant p53 conformation and functionScience19992862507251010617466
   PubMed Web of Science ®Google Scholar
• GautierLCopeLBolstadBMIrizarryRAAffy – analysis of affymetrix genechip data at the probe levelBioinformatics20042030731514960456
   PubMed Web of Science ®Google Scholar
• IrizarryRAHobbsBCollinFExploration, normalization, and summaries of high density oligonucleotide array probe level dataBiostatistics2003424926412925520
   PubMed Web of Science ®Google Scholar
• GentlemanRCareyVHuberWIrizarryRADudoitSBioinformatics and computational biology solutions using R and BioconductorNew YorkSpringer Science & Business Media2006
   Google Scholar
• KanehisaMGotoSKegg: kyoto encyclopedia of genes and genomesNucleic Acids Res200028273010592173
   PubMed Web of Science ®Google Scholar
• TarcaALDraghiciSKhatriPA novel signaling pathway impact analysisBioinformatics200925758218990722
   PubMed Web of Science ®Google Scholar
• DraghiciSStatistical intelligence: effective analysis of high-density microarray dataDrug Discov Today20027S55S6312047881
   PubMed Web of Science ®Google Scholar
• DrǎghiciSKhatriPMartinsRPOstermeierGCKrawetzSAGlobal functional profiling of gene expressionGenomics2003819810412620386
   PubMed Web of Science ®Google Scholar
• SubramanianATamayoPMoothaVKGene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profilesProc Natl Acad Sci U S A2005102155451555016199517
   PubMed Web of Science ®Google Scholar
• VaskeCJBenzSCSanbornJZInference of patient-specific pathway activities from multi-dimensional cancer genomics data using paradigmBioinformatics201026i237i24520529912
   PubMed Web of Science ®Google Scholar
• PedersenBSKonstantinopoulosPASpillmanMADeSCopy neutral loss of heterozygosity is more frequent in older ovarian cancer patientsGenes Chromosomes Cancer20135279480123716468
   PubMed Web of Science ®Google Scholar
• MatysVFrickeEGeffersRTransfac®: transcriptional regulation, from patterns to profilesNucleic Acids Res20033137437812520026
   PubMed Web of Science ®Google Scholar
• ZhaoMSunJZhaoZTsgene: a web resource for tumor suppressor genesNucleic Acids Res201341D970D97623066107
   PubMed Web of Science ®Google Scholar
• ChenJ-SHungW-SChanH-HTsaiS-JSunHSIn silico identification of oncogenic potential of fyn-related kinase in hepatocellular carcinomaBioinformatics20132942042723267173
   PubMed Web of Science ®Google Scholar
• FranceschiniASzklarczykDFrankildSString v9. 1: protein–protein interaction networks, with increased coverage and integrationNucleic Acids Res201341D808D81523203871
   PubMed Web of Science ®Google Scholar
• ShannonPMarkielAOzierOCytoscape: a software environment for integrated models of biomolecular interaction networksGenome Res2003132498250414597658
   PubMed Web of Science ®Google Scholar
• AdamcsekBPallaGFarkasIJDerényiIVicsekTCfinder: locating cliques and overlapping modules in biological networksBioinformatics2006221021102316473872
   PubMed Web of Science ®Google Scholar
• DerényiIPallaGVicsekTClique percolation in random networksPhys Rev Lett20059416020215904198
   PubMed Web of Science ®Google Scholar
• AshburnerMBallCABlakeJAGene ontology: tool for the unification of biologyNat Genet200025252910802651
   PubMed Web of Science ®Google Scholar
• PensonRTShannonKESharplessNESeidenMVOvarian cancer: an update on genetics and therapyCompr Ther1998244774879801846
   PubMedGoogle Scholar
• LüXLuHZhaoLYangYLuZGenome-wide pathways analysis of nickel ion-induced differential genes expression in fibroblastsBiomaterials2010311965197320053437
   PubMed Web of Science ®Google Scholar
• SerraVEichhornPJGarcía-GarcíaCRsk3/4 mediate resistance to pi3k pathway inhibitors in breast cancerJ Clin Invest20131232551256323635776
   PubMed Web of Science ®Google Scholar
• FanLLiPYinZRibosomal s6 protein kinase 4: a prognostic factor for renal cell carcinomaBr J Cancer20131091137114623942078
   PubMed Web of Science ®Google Scholar
• MeirowDBiedermanHAndersonRAWallaceWHBToxicity of chemotherapy and radiation on female reproductionClin Obstet Gynecol20105372773921048440
   PubMed Web of Science ®Google Scholar
• DhordainPAlbagliOHonoreNColocalization and heteromerization between the two human oncogene poz/zinc finger proteins, laz3 (bcl6) and plzfOncogene2000196240625011175338
   PubMed Web of Science ®Google Scholar
• KinugasaYHiedaMHoriMHigashiyamaSThe carboxyl-terminal fragment of pro-hb-egf reverses bcl6-mediated gene repressionJ Biol Chem2007282147971480617392284
   PubMed Web of Science ®Google Scholar
• YagiHYotsumotoFSonodaKKurokiMMekadaEMiyamotoSSynergistic anti-tumor effect of paclitaxel with crm197, an inhibitor of hb-egf, in ovarian cancerInt J Cancer20091241429143919048624
   PubMed Web of Science ®Google Scholar
• MiyamotoSHirataMYamazakiAHeparin-binding egf-like growth factor is a promising target for ovarian cancer therapyCancer Res2004645720572715313912
   PubMed Web of Science ®Google Scholar
• ShimuraTKataokaHOgasawaraNSuppression of prohb-egf carboxy-terminal fragment nuclear translocation: a new molecular target therapy for gastric cancerClin Cancer Res2008143956396518559618
   PubMed Web of Science ®Google Scholar
• DaviesFEDringAMLiCInsights into the multistep transformation of mgus to myeloma using microarray expression analysisBlood20031024504451112947006
   PubMed Web of Science ®Google Scholar
• ZouYTsaiWBChengCJForkhead box transcription factor foxo3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesisBreast Cancer Res200810R2118312651
   PubMed Web of Science ®Google Scholar
• FeiMZhaoYWangYLow expression of foxo3a is associated with poor prognosis in ovarian cancer patientsCancer Invest200927525919160093
   PubMed Web of Science ®Google Scholar
• HartwellLHKastanMBCell cycle control and cancerScience1994266182118287997877
   PubMed Web of Science ®Google Scholar
• HunterTPinesJCyclins and cancer ii: cyclin d and cdk inhibitors come of ageCell1994795735827954824
   PubMed Web of Science ®Google Scholar
• SuzukiTUranoTMikiYNuclear cyclin b1 in human breast carcinoma as a potent prognostic factorCancer Sci20079864465117359284
   PubMed Web of Science ®Google Scholar
• ArinagaMNoguchiTTakenoSClinical implication of cyclin b1 in non-small cell lung cancerOncol Rep2003101381138612883711
   PubMed Web of Science ®Google Scholar
• WangAYoshimiNInoNTanakaTMoriHOverexpression of cyclin b1 in human colorectal cancersJ Cancer Res Clin Oncol19971231241279030252
   PubMed Web of Science ®Google Scholar
• El-GhobashyAAShaabanAMHerodJInnesJPrimeWSimon HerringtonCOverexpression of cyclins a and b as markers of neoplastic glandular lesions of the cervixGynecol Oncol20049262863414766257
   PubMed Web of Science ®Google Scholar
• AgarwalRGonzalez-AnguloAMMyhreSIntegrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancerClin Cancer Res2009153654366219470724
   PubMed Web of Science ®Google Scholar
• YinX-YGroveLDattaNSKatulaKLongMWProchownikEVInverse regulation of cyclin b1 by c-myc and p53 and induction of tetraploidy by cyclin b1 overexpressionCancer Res2001616487649311522645
   PubMed Web of Science ®Google Scholar
• KidokoroTTanikawaCFurukawaYKatagiriTNakamuraYMatsudaKCdc20, a potential cancer therapeutic target, is negatively regulated by p53Oncogene2007271562157117873905
   PubMed Web of Science ®Google Scholar
• MondalGSenguptaSPandaCKGollinSMSaundersWSRoychoudhurySOverexpression of cdc20 leads to impairment of the spindle assembly checkpoint and aneuploidization in oral cancerCarcinogenesis200628819216777988
   PubMed Web of Science ®Google Scholar
• WeinsteinJNCollissonEAMillsGBThe cancer genome atlas pan-cancer analysis projectNat Genet2013451113112024071849
   PubMed Web of Science ®Google Scholar
• PedersenBSDeSLoss of heterozygosity preferentially occurs in early replicating regions in cancer genomesNucleic Acids Res201341167615762423793816
   PubMed Web of Science ®Google Scholar
• Rubio-PerezCTamboreroDSchroederMPIn silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunitiesCancer Cell20152738239625759023
   PubMed Web of Science ®Google Scholar
• CowardJIMiddletonKMurphyFNew perspectives on targeted therapy in ovarian cancerInt J Womens Health2015718925678824
   PubMed Web of Science ®Google Scholar
• ZhouHSchmidtSCJiangSEpstein-Barr virus oncoprotein super-enhancers control b cell growthCell Host Microbe20151720521625639793
   PubMed Web of Science ®Google Scholar
• PortalDZhouHZhaoBEpstein-Barr virus nuclear antigen leader protein localizes to promoters and enhancers with cell transcription factors and ebna2Proc Natl Acad Sci U S A2013110185371854224167291
   PubMed Web of Science ®Google Scholar
• ZhouHWongLComparative analysis and assessment of m. Tuberculosis h37rv protein–protein interaction datasetsBMC Genomics201112S2022369691
   PubMed Web of Science ®Google Scholar